Atrial fibrillation risk of ibrutinib compared with that of chemotherapy, targeted therapy, and next-generation Bruton's tyrosine kinase inhibitors: Updated systematic review and meta-analysis
@article{JTD119935,
author = {Shi Jiale and Li Wei and Liang Huazhen and Gong Hui-ping},
title = {Atrial fibrillation risk of ibrutinib compared with that of chemotherapy, targeted therapy, and next-generation Bruton's tyrosine kinase inhibitors: Updated systematic review and meta-analysis},
journal = {Journal of Thoracic Disease},
volume = {0},
number = {0},
year = {2026},
keywords = {},
abstract = {},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/119935}
}